Susan Mullin is an accomplished clinical operations leader with extensive experience in the biotechnology and pharmaceutical industries. Susan has held prominent positions, including Vice President of Clinical Operations at both Mirador Therapeutics and Ventyx Biosciences, as well as serving as Executive Director of Clinical Operations at Ventyx Biosciences. Previously, Susan was Senior Director of Clinical Operations at Arena Pharmaceuticals, Inc., and Director of Clinical Operations at Receptos, a wholly-owned subsidiary of Celgene. Early career roles at Bristol-Myers Squibb included responsibilities as Investigator Sponsored Research Capabilities Lead and various leadership positions within hematology and business development.
This person is not in the org chart
This person is not in any teams